Somerset Indus Capital Partners, a prominent healthcare-focused private equity (PE) firm, is on the verge of closing its third fund at a substantial $275 million, with commitments exceeding $250 million from a blend of existing and new limited partners (LPs). This imminent milestone, expected by October, showcases the firm’s adeptness at attracting institutional capital, with about 95% of the fund’s backing originating from development finance institutions (DFIs) both in India and overseas, along with a diverse array of LPs including global investment companies, European and American DFIs, financial banks, insurance companies, and impact investors spanning Europe and Southeast Asia.
The firm’s investment strategy centers on supporting first-generation entrepreneurs in the healthcare sector through growth equity investments ranging from $15-40 million. Somerset Indus has a robust track record, managing a portfolio of approximately $500 million across three funds, with notable investments in entities like Ujala Cygnus Hospitals and Krsnaa Diagnostics. The successful early deployment of capital from the upcoming third fund, with recent investments in Cyrix Healthcare and Printmann Offset, underscores the firm’s proactive approach towards fostering growth in healthcare enterprises.
Under the adept leadership of Mayur Sirdesai, a partner at Somerset Indus, the firm is keen on exploring burgeoning sub-segments within the healthcare landscape such as high-end diagnostics, point-of-care solutions, specialty clinics, preventive care, wellness, nutrition, and digital health. This forward-looking strategy aligns with industry trends where healthcare is evolving beyond mere recession resilience to becoming a sector characterized by consistent exits, prompting heightened investor interest and sector-specific funds dedicated to healthcare verticals.
The healthcare sector’s maturation is evidenced by the growing appetite for concentrated continuation vehicles (CVs) in India’s investment ecosystem, mirroring global trends. CVs, including single-asset vehicles, are emerging as strategic mechanisms for investors to retain successful portfolio companies that require extended gestation periods to realize their full potential. This trend signals a shift towards more specialized sector-focused investment strategies, with thematic funds gaining traction and even sector-agnostic firms pivoting towards developing domain expertise in specific sectors.
Somerset Indus’ differentiated approach of combining early-stage investments with potential buyouts in collaboration with buyout-focused PEs positions the firm strategically to support both organic and inorganic growth trajectories for its portfolio companies. By leveraging its successful track record and sector expertise, Somerset Indus aims to further catalyze the growth of healthcare enterprises, fostering innovation and excellence in areas such as diagnostics, wellness, and digital health.
Looking ahead, Somerset Indus is poised to capitalize on the evolving landscape of healthcare investments, with a focus on driving value creation, fostering innovation, and delivering sustainable growth across its portfolio. The firm’s commitment to supporting entrepreneurs, coupled with its deep sector knowledge and robust network of LPs, positions it favorably to navigate the dynamic healthcare industry landscape, creating long-term value for investors and stakeholders alike.
Key Takeaways:
– Somerset Indus Capital Partners is on track to close its third healthcare fund at $275 million, showcasing strong investor interest in the healthcare-focused PE sector.
– The firm’s strategic investment approach, focusing on early-stage growth equity investments and potential buyouts, underscores its commitment to fostering innovation and growth in the healthcare domain.
– Somerset Indus’ proactive stance towards exploring emerging sub-segments within healthcare, such as high-end diagnostics and digital health, aligns with industry trends and investor preferences for specialized sector-focused strategies.
– The maturation of the healthcare investment landscape, marked by the rise of concentrated continuation vehicles and thematic funds, highlights the evolving dynamics of the PE industry and the growing emphasis on sector expertise and value creation.
Read more on livemint.com